topic

Multiparametric MRI of early tumor response to immune checkpoint blockade in metastatic melanoma
Doreen Lau, Mary A McLean, Andrew N Priest, Andrew B Gill, Francis Scott, Ilse Patterson, Bruno Carmo, Frank Riemer, Joshua D Kaggie, Amy Frary, Doreen Milne, Catherine Booth, Arthur Lewis, Michal Sulikowski, Lee Brown, Jean-Martin Lapointe, Luigi Aloj, Martin J Graves, Kevin M Brindle, Pippa G Corrie, Ferdia A Gallagher

Journal for ImmunoTherapy of Cancer Sep 2021, 9 (9) e003125; DOI: 10.1136/jitc-2021-003125
Novel potent anti-STEAP1 bispecific antibody to redirect T cells for cancer immunotherapy
Tsung-Yi Lin, Jeong A Park, Alan Long, Hong-Fen Guo, Nai-Kong V Cheung

Journal for ImmunoTherapy of Cancer Sep 2021, 9 (9) e003114; DOI: 10.1136/jitc-2021-003114
Elevated T cell repertoire diversity is associated with progression of lung squamous cell premalignant lesions
Asaf Maoz, Carter Merenstein, Yusuke Koga, Austin Potter, Adam C Gower, Gang Liu, Sherry Zhang, Hanqiao Liu, Christopher Stevenson, Avrum Spira, Mary E Reid, Joshua D Campbell, Sarah A Mazzilli, Marc E Lenburg, Jennifer Beane

Journal for ImmunoTherapy of Cancer Sep 2021, 9 (9) e002647; DOI: 10.1136/jitc-2021-002647
Functional analysis of peripheral and intratumoral neoantigen-specific TCRs identified in a patient with melanoma
Eva Bräunlein, Gaia Lupoli, Franziska Füchsl, Esam T Abualrous, Niklas de Andrade Krätzig, Dario Gosmann, Lukas Wietbrock, Sebastian Lange, Thomas Engleitner, Huan Lan, Stefan Audehm, Manuel Effenberger, Melanie Boxberg, Katja Steiger, Yinshui Chang, Kai Yu, Cigdem Atay, Florian Bassermann, Wilko Weichert, Dirk H Busch, Roland Rad, Christian Freund, Iris Antes, Angela M Krackhardt

Journal for ImmunoTherapy of Cancer Sep 2021, 9 (9) e002754; DOI: 10.1136/jitc-2021-002754
Eosinophilic features in clear cell renal cell carcinoma correlate with outcomes of immune checkpoint and angiogenesis blockade
Takashi Yoshida, Chisato Ohe, Junichi Ikeda, Naho Atsumi, Haruyuki Ohsugi, Motohiko Sugi, Koichiro Higasa, Ryoichi Saito, Koji Tsuta, Tadashi Matsuda, Hidefumi Kinoshita

Journal for ImmunoTherapy of Cancer Sep 2021, 9 (9) e002922; DOI: 10.1136/jitc-2021-002922
Correction: Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design
Journal for ImmunoTherapy of Cancer Oct 2021, 9 (10) e003149corr1; DOI: 10.1136/jitc-2021-003149corr1
Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cells
Justin T Huckaby, Elisa Landoni, Timothy M Jacobs, Barbara Savoldo, Gianpietro Dotti, Samuel K Lai

Journal for ImmunoTherapy of Cancer Sep 2021, 9 (9) e002737; DOI: 10.1136/jitc-2021-002737
Trends in clinical development of pediatric cancer for PD-1 and PD-L1 inhibitors: an analysis of ClinicalTrials.gov
Yi Que, Yang Hu, Dongchun Hong, Yizhuo Zhang

Journal for ImmunoTherapy of Cancer Sep 2021, 9 (9) e002920; DOI: 10.1136/jitc-2021-002920
Leveraging the Treg-intrinsic CTLA4–PKCη signaling pathway for cancer immunotherapy
Hsin-Yu Liu, Christophe Pedros, Kok-Fai Kong, Ann J Canonigo-Balancio, Wen Xue, Amnon Altman

Journal for ImmunoTherapy of Cancer Sep 2021, 9 (9) e002792; DOI: 10.1136/jitc-2021-002792
Correction: Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies
Journal for ImmunoTherapy of Cancer Sep 2021, 9 (9) e002591corr1; DOI: 10.1136/jitc-2021-002591corr1

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages